Newsmeme!
Discover News you didn't know existed

• home
• news
• tagging
• how it works
• about
• data

Tumor Markers

News

Response Genetics Signs Amendment to Its Master Service Agreement With GlaxoSmithKline as Preferred Provider of ...

Published January 2, 2009, 1:26 pm, Centre Daily Times

Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, announced today it has signed an amended and restated master service agreement with GlaxoSmithKline, Ltd. (NYSE:GSK). This agreement extends the current agreement between the companies for a two-year period and names Response Genetics as preferred provider of genetic ...

Full Story

Tags

No tags found at this time. Be the first to tag this news item, learn more.

Imagery

No related imagery found.

Related Tumor Markers Stories

From Various News Sources

Response Genetics Signs Amendment to Its Master Service Agreement With ... - StreetInsider.com
Response Genetics Signs Amendment to Its Master Service Agreement With GlaxoSmithKline as Preferred Provider of Genetic Testing Services Notable Mergers and Acquisitions of the Day 12/30: HSSO/EMAG, WSTF, GSK/GNLB GlaxoSmithKline (GSK) Reduces ...

Related Social Bookmarks

June 6th

Serum Tumor Markers in Breast Cancer: Are They of Clinical Value? -- Duffy 52 (3): 345 -- Clinical Chemistry: Serum Tumor Markers in Breast Cancer: Are They of Clinical Value?

May 20th

Testicular Cancer Information: Information and personal stories on Testicular Cancer Gathered from a Testicular Cancer Survivor

May 6th

Testicular Cancer Information and News Updated daily: An assembly of information about Testicular Cancer. Today treateable in almost 99% of all cases. Knowledge about Testicular Cancer is very important. Please read.